Ark Biopharmaceutical

Shanghai Ark Biopharmaceutical Co., Ltd (ArkBio), a Chinese biopharmaceutical company, has entered into a partnership with SDODT, a domestic innovator in digital therapeutics technology. The collaboration aims to enhance the marketing and commercialization efforts for products targeting Attention Deficit Hyperactivity Disorder (ADHD) treatment. ADHD is a prevalent chronic neurodevelopmental disorder…